SCHEMBL20219666

SCHEMBL20219666

CCCC(C)Nc1nc(N)ncc1OCc1cn2ccccc2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 2/20 0.44
▸ SMN1; SMN2 Q16637 6/20 0.43
▸ NPC1 O15118 6/20 0.43
▸ RAB9A P51151 6/20 0.43
▸ KDM4E B2RXH2 5/20 0.43
▸ LMNA P02545 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ HRH4 Q9H3N8 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ TLR8 Q9NR97 1/20 0.41
▸ TSHR P16473 1/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ PDE10A Q9Y233 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ SIRT5 Q9NXA8 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ PKM P14618 1/20 0.35
▸ NFKB1 P19838 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15470285 1.00 TLR7 (0.44) TLR7SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL15470282 1.00 TLR7 (0.44) TLR7SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL23472299 0.89 NPC1 (0.44) TLR7SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL15470199 0.88 TLR8 (0.44) TLR7SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL15470178 0.87 KCNH2 (0.46) TLR7SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL15470210 0.84 TLR8 (0.47) TLR7SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL13195702 0.84 TLR7 (0.60) TLR7SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL15470181 0.84 KCNH2 (0.48) TLR7SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL19274232 0.79 SMN1; SMN2 (0.41) TLR7SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL19274250 0.79 SMN1; SMN2 (0.43) TLR7SMN1; SMN2NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3590928-B1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS JANSSEN SCIENCES IRELAND UNLIMITED CO (IE) 2021-06-09 — — EP disclosed
EP-3330257-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS Janssen Sciences Ireland UC (IE) 2018-06-06 — — EP disclosed
Send feedback